LabCompass

Chunhua Song

Medicine · The Ohio State University

Established · publishing since 1992

Publications

238

Citations

4,966

Est. group size

Recurring co-author estimate

Active years

35

Publishing since 1992

Research summary
AI-generated

Chunhua Song's work centers on blood cancers, especially acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and myelodysplastic neoplasms, examining genetic mutations, drug combinations, and cell signaling pathways that drive disease progression and treatment response. The research also extends into broader cancer prognosis studies (e.g., biomarkers for survival in gastrointestinal and esophageal cancers) and some unrelated work on metabolic liver disease and algae biotechnology. Publications span laboratory-based molecular studies and clinical/retrospective analyses.

Leukemia biology and genetics (ALL, AML, CML, CLL)Cancer treatment combinations and drug efficacyCancer prognosis and survival biomarkersMolecular signaling pathways (e.g., PI3K/AKT, ubiquitination)Metabolic and liver disease research

Publication output has gradually declined from around 19-21 papers per year in 2017-2019 to about 12-13 papers per year in recent years, suggesting a slowing pace of output.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 12.0/year recently
2017: 19 publications172018: 17 publications182019: 21 publications21192020: 14 publications202021: 12 publications212022: 17 publications222023: 16 publications232024: 13 publications242025: 13 publications252026: 1 publication26
Recent publications
Publishes in
  • Blood×40
  • Cancer Research×17
  • HemaSphere×7
  • International Journal of Molecular Sciences×6
  • The FASEB Journal×6
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile